Comparison of survival between cerebellar and supratentorial glioblastoma patients: Surveillance, epidemiology, and end results (SEER) analysis

Neurosurgery

Volumn 73, Issue 2, 2013, Pages 240-246

  Jeswani, Sunil ^a   Nuño, Miriam ^a   Folkerts, Vanessa ^a   Mukherjee, Debraj ^a   Black, Keith L ^a   Patil, Chirag G ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Case control study; Cerebellar glioblastoma; Gross total resection; Overall survival time; Radiation; Supratentorial glioblastoma

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CEREBELLUM TUMOR; CONTROLLED STUDY; FEMALE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPENSITY SCORE; SURVIVAL; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CASE-CONTROL STUDIES; CEREBELLAR NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SUPRATENTORIAL NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84880920769     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.neu.0000430288.85680.37     Document Type: Article

References (16)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987-996.
2. Levine SA, McKeever PE, Greenberg HS. Primary cerebellar glioblastoma multiforme. J Neurooncol. 1987;5(3):231-236.
3. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6(3):227-235.
4. Stark AM, van de Bergh J, Hedderich J, Mehdorn HM, Nabavi A. Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg. 2012;114(7):840-845.
5. Tsung AJ, Prabhu SS, Lei X, et al. Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution. J Neurooncol. 2011;105(3):555-562.
6. Weber DC, Miller RC, Villà S, et al. Outcome and prognostic factors in cerebellar glioblastoma multiforme in adults: a retrospective study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys. 2006;66(1):179-186.
7. Djalilian HR, Hall WA. Malignant gliomas of the cerebellum: an analytic review. J Neurooncol. 1998;36(3):247-257.
8. Surveillance E, and End Results (SEER) program (http://www.seer.cancer. gov)
9. Saito T, Hama S, Kajiwara Y, et al. Prognosis of cerebellar glioblastomas: correlation between prognosis and immunoreactivity for epidermal growth factor receptor compared with supratentorial glioblastomas. Anticancer Res. 2006;26(2B):1351-1357.
10. Stark AM, Maslehaty H, Hugo HH, Mahvash M, Mehdorn HM. Glioblastoma of the cerebellum and brainstem. J Clin Neurosci. 2010;17(10):1248-1251.
11. Utsuki S, Oka H, Miyajima Y, et al. Adult cerebellar glioblastoma cases have different characteristics from supratentorial glioblastoma. Brain Tumor Pathol 2012;29(2):87-95.
12. Johnson DR, O'Neill BP. Glioblastoma survival in the United States before and during the temozolomide era. JNeurooncol 2012;107(2):359-364.
13. Filippini G, Falcone C, Boiardi A, et al. Prognostic factors for survival in 676 consecutive patients with newly diagnosed primary glioblastoma. Neuro Oncol. 2008;10(1):79-87.
14. Lacroix M, Abi-Said D, Fourney DR, et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg. 2001;95(2):190-198.
15. Lutterbach J, Sauerbrei W, Guttenberger R Multivariate analysis of prognostic factors in patients with glioblastoma. Strahlenther Onkol. 2003;179(1):8-15.
16. Ewelt C, Goeppert M, Rapp M, et al. Glioblastoma multiforme of the elderly: the prognostic effect of resection on survival. J Neurooncol. 2011;103(3):611-618.